Area served Global Founded 2001 | Website www.hopelab.org Type Nonprofit organization | |
Products Re-Mission and Re-Mission 2, Zamzee, Mood Meter, Greater Good in Action, Text to Connect Headquarters Redwood City, California, United States Similar Omidyar Network, Games for Change, California Health Care Fou, Great Lakes Higher E, Michael & Susan Dell Foundation Profiles | ||
Hopelab combining science design to help people thrive
HopeLab is a 501(c)(3) private operating foundation based in Redwood City, CA. HopeLab researches and develops technology-based products to improve human health and well-being. The foundation now focuses on resilience research as part of a strategy to design products that support the psychological and biological health of individuals and communities. The foundation was established in 2001 by Pam Omidyar and is part of the Omidyar Group of philanthropic enterprises founded and funded by Pam and her husband Pierre Omidyar, founder and chairman of eBay.
Contents
- Hopelab combining science design to help people thrive
- Re mission video game cigna and hopelab initiative
- Resilience
- Zamzee
- Re Mission
- Re Mission 2
- Partnerships
- Research and Publications
- Articles
- References
HopeLab is the recipient of the 2014 Drucker Award for Nonprofit Innovation for its pioneering work in creating products that help people respond to life’s adversity in healthy ways. HopeLab also has been named a Social Enterprise of the Year by Fast Company magazine and was recognized by President Obama and the White House Office of Social Innovation and Civic Participation for innovating new approaches to improving the health of young people. For her work with HopeLab, Pam Omidyar received the inaugural Peter Samuelson Award for Innovation at the Starlight Children's Foundation in 2007.
Re mission video game cigna and hopelab initiative
Resilience
Although HopeLab has not yet unveiled a product that promotes resilience, the foundation is working to catalyze the development of mobile apps and other technologies to enhance resilience in people’s everyday lives. HopeLab defines resilience as “the ability to bounce back from adversity” and holds the point of view that resilience is an innate human trait. According to HopeLab, scientific research has helped identify three major modifiable sources of resilience that affect both psychological and biological health:
HopeLab is working to establish measurement tools for both biological and psychological resilience, using genomics technology and Big Data analytics. The foundation is also sourcing collaborative development opportunities to explore how technology can support resilience and, in a more targeted application, help address the problem of bullying, both online and offline.
As part of HopeLab’s development path, the foundation is presenting new psychological and social intervention concepts from research in psychology, medicine, and neuroscience to the product developer and design community. The foundation is also providing seed grants, prototyping and testing apps for early stage impact at behavioral and biological levels, and driving iterative refinements of any product or technology that shows empirical promise.
Zamzee
Zamzee is a game-based product prototyped and tested by HopeLab as a tool to motivate children, families and groups to be more physically active. The product combines an activity tracker that records physical activity and a motivational website where activity is rewarded with points and prizes. Data from a randomized, controlled study conducted by HopeLab, with support from the Robert Wood Johnson Foundation, showed that middle-school children using Zamzee boosted their physical activity levels by 59% compared to a control group. The study also showed significant increases in physical activity for at-risk groups, including a 103% increase among girls and 27% increase among overweight participants. Other outcomes included positive impacts on LDL cholesterol and glycated hemoglobin, key biomarkers for heart disease and type 2 diabetes. These results were announced at the 2012 Obesity Society Annual Meeting in San Antonio, Texas.
To begin its development of physical activity interventions, HopeLab, in partnership with the Robert Wood Johnson Foundation's Pioneer Portfolio launched an online competition called Ruckus Nation on September 18, 2007. The competition was structured as a form of crowdsourcing, and its objective was to generate ideas for products that will encourage children ages 11–14 to be more physically active. The competition was international in scope, open to people of all ages, with a total prize purse of more than 300,000 USD awarded to winners across four competition categories. More than 1,142 people registered to compete, and 429 ideas were submitted by teams representing 37 countries and 41 U.S. states. Contestants ranged in age from 6 to 82 years of age. Semifinalist teams were announced March 10, 2008. On March 17, 2008, 10 category winners, one grand prize winner, and one grand prize honorable mention were announced at an event at the de Young Museum of Fine Arts in San Francisco, California.
In 2010 HopeLab launched Zamzee Co., a for-profit enterprise with a social mission to get kids and families moving more. HopeLab provided seed funding to the enterprise by way of a program-related equity investment of $1 million. Zamzee Co.’s objective was to market and conduct ongoing development of the Zamzee product, introducing features like Zamzee Family View and Zamzee for Groups.
In 2015, Zamzee was acquired by Welltok, developers of the CaféWell Health Optimization Platform™. As part of Welltok, Zamzee will continue to help kids and families lead healthier, more active lives.
Re-Mission
HopeLab's first product is the Re-Mission video game for teens and young adults with cancer. Released on April 3, 2006, the game is a Microsoft Windows based third-person shooter based in the serious games genre. The game was conceived by Pam Omidyar and designed based on HopeLab research, direct input from young cancer patients and oncology doctors and nurses, and game developer Realtime Associates, among others. The game was designed to engage young cancer patients through entertaining game play while impacting specific psychological and behavioral outcomes associated with successful cancer treatment.
HopeLab conducted an international, multicenter randomized controlled trial to gauge the efficacy of Re-Mission as it relates to compliance with prescribed chemotherapy and antibiotic treatments, cancer-related knowledge, and self-efficacy. The study enrolled 375 cancer patients aged 13–29 at 34 medical centers in the United States, Canada, and Australia. Subjects received either computers pre-loaded with a popular commercial video game (the control group) or computers preloaded with the same control game plus Re-Mission. Study results indicated that playing Re-Mission led to more consistent treatment adherence, faster rate of increase in cancer knowledge, and faster rate of increase in self-efficacy in young cancer patients. These findings were published in August 2008 in the peer-reviewed medical journal Pediatrics. Notably, to ascertain treatment compliance, researches used objective blood tests to measure levels of prescribed chemotherapy in the bodies of study participants rather than subjective self-report questionnaires, and electronic pill-cap monitors were used to determine utilization of prescribed antibiotics. Researchers concluded that a carefully designed video game can have a positive impact on health behavior in young people with chronic illness and that video-game–based interventions may constitute a component of a broader integrative approach to healthcare that synergistically combines rationally targeted biological and behavioral interventions to aid patients in the prevention, detection, treatment, and recovery from disease.
HopeLab conducted additional research to understand the mechanisms of action that make Re-Mission effective. Results of an fMRI study of Re-Mission showing the impact of the game on neurological processes were presented in August 2008 at the 10th International Congress of the Society of Behavioral Medicine. This research informed HopeLab's development of the next version of Re-Mission.
HopeLab makes Re-Mission available at no charge to young people with cancer and their families, as well as oncology healthcare workers and institutions around the world. Copies are also distributed at no charge to others, though donations are accepted. The game can be downloaded or ordered at re-mission.net in English, Spanish, or French. The Re-Mission website also includes an online community where teens and young adults can share information and support each other.
As of June 2013, more than 202,000 copies of Re-Mission have been distributed in 81 countries, placing it among the most successful serious games to date. HopeLab engages organizations and individuals worldwide to facilitate distribution of the game to teens and young adults with cancer. On May 30, 2007, CIGNA HealthCare announced a partnership with HopeLab in which CIGNA distributes copies of Re-Mission to its members at no cost. HopeLab has also partnered with Starlight Children's Foundation and the Entertainment Software Association (ESA) Foundation to distribute Re-Mission.
Re-Mission 2
Re-Mission 2, a collection of free online games, is the follow-up to HopeLab’s Re-Mission video game, released in 2006. Re-Mission 2 is designed to improve psychological and behavioral outcomes associated with cancer treatment adherence. Each game puts players inside the body to fight cancer with weapons like chemotherapy, antibiotics and the body’s natural defenses. Game play parallels real-world strategies used to fight cancer and win. More than 120 young people with cancer participated in the research and development of the games.
Re-Mission 2 applies insights from a brain-imaging study published in 2012 by HopeLab and Stanford University researchers, showing that the Re-Mission video game strongly activates brain circuits involved in positive motivation. This reward-related activation is associated with a shift in attitudes and emotions that helped boost players’ adherence to prescribed chemotherapy and antibiotic treatments in a previous study. As a result, each Re-Mission 2 game is designed to boost positive emotion, increase self-efficacy, and shift attitudes toward chemotherapy.
The games are designed specifically for teens and young adults who are at risk of adverse cancer outcomes due to poor treatment adherence. Research on Re-Mission 2 shows that the new games are as effective as the original Re-Mission game in increasing players’ self-efficacy, boosting positive emotions and shifting attitudes about chemotherapy.
Re-Mission 2 games are free to play online at re-mission2.org, and Re-Mission 2: Nanobot’s Revenge is available for download as a mobile app for iOS and Android devices. The browser-based games and mobile app offer a variety of gameplay styles for young cancer patients who spend time online and on mobile devices.
Partnerships
As part of HopeLab’s development approach, the foundation works with research partners and organizations to scale projects more broadly. Current partnerships of HopeLab include:
Research and Publications
Research and product development are led by Dr. Steve Cole, focusing on scientific studies and user-centered design approaches to understand how social technologies impact the mind and body to improve the health of young people. As an active biomedical scientist, Dr. Cole also serves as a Professor of Medicine in the Division of Hematology-Oncology at UCLA. His research analyzes how social factors influence gene expression in the immune system. His laboratory develops new mathematical tools for analyzing complex gene networks in cancer and infectious diseases. One of his studies was cited as one of Discover Magazine’s Top 100 Science Stories of 2007.
HopeLab research and journal articles include: